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Increased cannabInoIds concentratIons Found In specImens From Fatal avIatIon accIdents between 1997 and 2006

INTrOduCTION
Although t remans the most commonly used llct drug n the unted states cannabs use has declned slghtly over the past 10 years.
1, 2 however, the potency of cannabs, as measured by delta-9-tetrahydrocannabnol (thc) concentratons, has nearly doubled from 1997 to 2006. 3 ths ncreased potency could result n hgher concentratons of thc and ncdence of mparment n persons workng n the transportaton ndustry. It has also been reported that marjuana use dsorders among cannabs users, whch are already the most prevalent llct substance use dsorders n the populaton, ncreased sgnficantly (P=0.002) between 1991-1992 and 2001-2002 n the absence of ncreased frequency and quantty of cannabs use, suggestng that concomtant ncreased cannabs potency may have contrbuted to the rsng rates of cannabs use dsorders. 4 recent studes have shown that cannabs users choose to smoke hgh-potency cannabs more often than lowpotency cannabs. 5 hgh-potency cannabs users wll generally ncrease ther average thc ntake. 6 there are contradctory reports that subjects do not regulate ther cannabs smoke ntake n response to changes n cannabs potency 7 and that they do ttrate ther ntake. 8 If cannabs users do ttrate the amount of cannabs used based on ts potency, one would not expect a sgnficant ncrease n the concentraton of cannabnods found n blood samples collected over a 10-year perod durng whch the potency of the cannabs sgnficantly ncreased.
Most of the earler performance studes used lowpotency cannabs, compared to the potency of cannabs avalable today, and probably do not reflect the performance mparment potental of hgh-potency cannabs. 9 studes conducted wth hgh-potency cannabs have demonstrated consstent mparment of executve functon, trackng performance, and motor mpulse control. 6 the mparment was shown to last for up to 6 hours after smokng. there s other recent evdence that the use of cannabs s not harmless. 4, 10, 11 research has shown that thc concentratons n blood between 3.5-5.0 ng/ml (plasma 7-10 ng/ml) have an mparng effect on drvers equvalent to a blood alcohol concentratons 0.05%. 12 the FAA prohbts plots from operatng an arcraft wth blood alcohol concentratons at or above 0.04%. that rases the queston of how many avaton accdents are found wth plots havng blood thc concentratons at or above the mparng range, compared to fatal avaton accdents that occurred pror to the avalablty of hgh-potency cannabs.
ths study was undertaken to compare the change n reported cannabs potency wth changes n the concentratons of thc and ts 11-nor-9-carboxy-thc (thc-cOOh) metabolte found n urne and blood from fatal avaton accdents durng the perod from 1997 to 2006.
mATErIAls ANd mEThOds
the cvl Aerospace Medcal Insttute (cAMI) receves bologcal fluds and tssues for toxcology analyss from all avaton accdents that occur natonwde. Blood specmens receved from plots are screened for thc-cOOh by radommunoassay (rIA) and urne specmens by fluorescence polarzaton mmunoassay (FPIA). sold phase extracton s used to solate thc and thc-cOOh from blood and urne. the confirmaton and quanttaton of thc-cOOh n urne s performed usng gas chromatography and electron mpact mass spectrometry (Gc/Ms). thc and thc-cOOh n blood are confirmed and quanttated by negatve-on chemcal onzaton Gc/Ms, based on a modficaton of a procedure publshed n 1983. 13 the procedure used to analyze cannabnods ncludes deuterated nternal standards and has a lmt of detecton and a lmt of quanttaton of 1 ng/ml n blood and urne.
A 10-year perod from 1997 to 2006 was selected for ths study to correlate wth data reported by the natonal Insttute on drug Abuse (nIdA) and the Office of natonal drug control Polcy (OndcP) on cannabs potency.
3 cannabnods concentratons n blood and urne were compared wth the reported potency of cannabs durng the same tme perod. postve ndvduals, 39% were also found postve for other mparng drugs. Blood was receved for analyss from 1676 fataltes. urne was receved for analyss from 1650 fatally njured ndvduals. cannabnods were found n 88 (5.3%) of the 1676 blood specmens receved for analyss, and 64 of these were from plots. cannabnods were found n 68 (4.1%) of the 1650 urne specmens receved for analyss; 57 of these were from plots. the medan age for cannabs users was 42 years among the fatally njured avaton ndvduals, wth a range from 18 to 72 (Fgure 1). For negatve cannabnods n blood and urne specmens tested, the medan age was 50 years, wth a span from 14 to 92. More than half of the fatally njured persons tested were 50 years or older, whereas 80% of the cannabs users were under 50. thc concentratons n blood ranged from 0 to 68ng/ml, wth a mean of 5.5 ng/ml. thc-cOOh concentratons n blood ranged from 0 to 179 ng/ml, wth a mean of 17.5 ng/ml. urne concentratons of thc-cOOh ranged from 2 to 1,113 ng/ml, wth a mean of 137.9 ng/ml.
Between 1997 and 2001, 8 postve thc cases of 55 postve cannabnods cases n blood were at or above 3.5 ng/ml, whle 20 of the reported 51 postve cannabs cases n blood from 2002 to 2006 were at or above 3.5 ng/ml. ths s more than a two-fold ncrease over those years wth lower cannabs potency.
the data ndcated an approxmately 1/10 blood/urne thc-cOOh rato for urne thc-cOOh concentratons above 15 ng/ml. For urne thc-cOOh concentratons at or below 15 ng/ml, there was an approxmately 1/2 blood/urne thc-cOOh rato. the rato of the mean blood thc concentraton to the mean urne thc-cOOh concentraton for urne specmens wth thc-cOOh concentratons at or below 15 ng/ml was 1/3 and 1/50 for concentratons above 15 ng/ml. the mean concentraton of thc n blood for the perod 1997-2001 was 2.7 ng/ml t was 7.2 ng/ml for 2002-2006, a 2.7-fold ncrease n the mean thc concentraton of specmens from avaton fataltes. the annual mean thc concentraton found n blood ncreased from 1.3 ng/ml n 1997 to 14.8 ng/ml n 2006, an 11.3-fold ncrease. the annual maxmum thc concentraton found n blood ncreased from 8 ng/ml n 1997 to 65 ng/ml n 2006, an 8.1-fold ncrease.
the mean concentraton of thc-cOOh n blood for the perod 1997-2001 was 11.6 ng/ml, and for 2002-2006 t was 23.5 ng/ml, a 2.0-fold ncrease n the mean thc-cOOh concentraton of specmens from avaton fataltes. the annual mean thc-cOOh concentraton found n blood ncreased from 11.6 ng/ml n 1997 to 56.0 ng/ml n 2006, a 4.8-fold ncrease. the annual maxmum thc-cOOh concentraton found n blood ncreased from 41 ng/ml n 1997 to 179 ng/ml n 2006, a 4.4-fold ncrease.
urne specmens were receved from 740 fatally njured plots desgnated as arlne transport or commercal plots, and 14 (1.9%) of the commercal plot cases exceeded the dOt workplace drug testng urne thc-cOOh confirmaton threshold (15 ng/ml). 14 no cannabnods were found n specmens from the arlne transport plots tested. eght (57%) fatally njured commercal plots (ncludng agrcultural plots) found wth a urne thc-cOOh n excess of the dOt workplace drug testng urne threshold were flyng prvate planes. urne specmens from fatally njured agrcultural plots (Part 137) were found to exceed the dOt workplace drug testng threshold thc-cOOh n 5 (36%) Figure 1 . Graphic display of age distribution for all fatal pilots and cannabis users. In 2006, 0.05 % of the ndvduals (flght crewmembers) tested n the FAA avaton ndustry random drug testng program were found to be postve for marjuana; 15 6.0% of the commercal plots tested n the cAMI forensc drug testng laboratory (fatal avaton accdent plots) were postve for thc-cOOh at or above the threshold of 15 ng/ml thc-cOOh n urne . the commercal plots tested n the cAMI forensc toxcology department for 2006 were flyng prvate planes (Part 91) or crop dusters (Part 137). not all commercal plots (agrcultural plots, for example) are requred to partcpate n the random drug testng program.
Government agences and the scentfic lterature repeatedly reported that the potency of cannabs has been ncreasng over the 10 years of ths study. 3, 16, 17 the mean concentraton of thc n blood specmens from fatal avaton accdents tested by cAMI has also ncreased over the last 10 years, but at a greater rate than marjuana potency (Fgure 2). research conducted n sweden also found an ncrease n the mean concentraton of thc n blood from 1.8 to 2.3 ng/ml n a 10-year (1995-2004) study of drug mpared drvers. 18 controlled laboratory experments on drvng-related sklls reported n the lterature have shown that thc concentratons between 2 and 5 ng/ml n whole blood are assocated wth drver mparment. 19 serum thc concentratons between 7-10 ng/ml (whole blood, approxmately 3.5-5.0 ng/ml) have been compared to a blood alcohol concentraton of 0.05%, 12 whch exceeds the dOt alcohol threshold of 0.04% (BAc) for transportaton workers n safety-senstve postons. It s clear that the use of hgh-potency cannabs could sgnficantly alter the performance of an ndvdual, assumng the blood thc concentratons ncrease correspondngly.
In a study n norway, 589 (2.0%) samples of approxmately 30,000 samples from mpared drvers were found to contan only thc as the mparng drug. 20 the norway epdemologcal study ndcated an assocaton of drvng mparment n ndvduals at or above 2.5 ng/ ml thc n blood and found no mparment at blood thc concentratons at or below 1.9 ng/ml n suspected drugged drvers. 20 of a lnear, dose-related, physologcal response to thc. 21 "Furthermore, drvers wth blood thc concentratons above 3 ng/ml had an ncreased rsk for beng judged mpared compared to drvers wth lower concentraton ranges . " 20 In our research, we found that approxmately 46 % (22/48) of the blood samples postve for thc from 2002-2006 had concentratons of thc greater than 3.5 ng/ml, whereas only 25 % (10/40) exceeded that concentraton between 1997 and 2001.
Although there were only 95 cannabnods-postve cases reported n ths study, cannabs use may be more prevalent n the drvng populaton and n other modes of transportaton. A 10-year study from 1995 to 2004 of drug mpared drvers n sweden found that 8,794 drvers had thc n ther blood; 18 consttutng a proporton rsng from 18 to 29 % of all tested specmens durng that decade. ths suggests that the prevalence of thc n the drvng populaton s far hgher than we found n avaton fataltes.
A study of 1,079 commercal tractor-traler drvers n the state of Washngton found that 4.3% of the drvers were usng cannabs, whle 1.3 % of the drvers were usng alcohol; 22 cannabs use n truck drvers was 3.3 tmes as prevalent as alcohol use n ths 2002 report. 22 In our study of avaton fataltes cannabs use was found to be 1.7 tmes greater than alcohol use at or above 40 mg/dl n blood or urne. these findngs are contrary to the wdely held percepton that alcohol s the most commonly abused drug n transportaton. It s also mportant to recognze that some of the alcohol postve cases found n avaton fataltes n ths study could have been the result of postmortem ethanol formaton. 23 cannabs use n conjuncton wth other mparng substances such as alcohol has been reported to sgnficantly ncrease the drvng mparment of an ndvdual and to cause mparment by cannabs at much lower concentratons than 3.5 ng/ml of thc n whole blood. 24 ths study found that 39% of the postve cannabnods cases were also postve for other mparng substances.
In a study of thc postve drvers n sweden, the mean age was reported as 33 years, wth a range of 15-66 years. 18 In our study, the mean age for cannabs users was 40 years for avaton fataltes, wth an age range of 18-72. For all blood and urne specmens tested at cAMI, the mean age was 50 years wth a range of 14-92. More than half of all fatally njured ndvduals tested were 50 years, or older; however, 80% of the cannabnods users were under 50. It appears from these data that younger ndvduals were more lkely to be usng cannabs n avaton, just as n the general populaton. the drvng populaton s younger than the flyng populaton, and would be more lkely to use cannabs and be subject to mparment from the effects of hgh-potency cannabs. the percentage of cannabs users n motor vehcle accdents could be greater than that found n fatal avaton accdents because of the age dfferences between drvers and plots, among other factors.
